Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × Radiotherapy, Conformal × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Gliosarcoma 7 Prostatic Neoplasms 6 Glioblastoma 6 Lung Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Brain Neoplasms 4 Sarcoma 3 Breast Neoplasms 3 Malignant mesenchymal tumor 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Fibrosarcoma 2 Central Nervous System Neoplasms 2 Astrocytoma 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Adenocarcinoma of Lung 2 Vulvar Neoplasms 1 Vomiting 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Radiodermatitis 1

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡